Given the results of the clinical studies of [28,64] and in vitro cell culture data [23-27,62,65], it is not unreasonable to hypothesize that targeting ENOSF1 catalytic activity or possible interactions with other proteins may lead to increased apoptosis in tumours. The gene discussed is ENOSF1; the disease is neoplasm.